Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 27 entries
Sorted by: Best Match Show Resources per page
[POSSIBILITY OF PROGNOSTIC EVALUATION OF HODGKIN'S DISEASE AFTER RADIOTHERAPY].

La Radiologia medica

DALLAPALMA L, CAVINA C, PELU G, CIAMPELLI L.
PMID: 14219976
Radiol Med. 1964 Oct;50:1008-25.

No abstract available.

Cite
DALLAPALMA L, CAVINA C, PELU G, et al. POSSIBILIT'A DI VALUTAZIONE PROGNOSTICA DEL MORBO DI HODGKIN DOPO RADIOTERAPIA. [POSSIBILITY OF PROGNOSTIC EVALUATION OF HODGKIN'S DISEASE AFTER RADIOTHERAPY]. Radiol Med. 1964;50:1008-25
DALLAPALMA, L., CAVINA, C., PELU, G., & CIAMPELLI, L. (1964). POSSIBILIT'A DI VALUTAZIONE PROGNOSTICA DEL MORBO DI HODGKIN DOPO RADIOTERAPIA. [POSSIBILITY OF PROGNOSTIC EVALUATION OF HODGKIN'S DISEASE AFTER RADIOTHERAPY]. La Radiologia medica, 501008-25.
DALLAPALMA, L, et al. "POSSIBILIT'A DI VALUTAZIONE PROGNOSTICA DEL MORBO DI HODGKIN DOPO RADIOTERAPIA." [POSSIBILITY OF PROGNOSTIC EVALUATION OF HODGKIN'S DISEASE AFTER RADIOTHERAPY]. La Radiologia medica vol. 50 (1964): 1008-25.
DALLAPALMA L, CAVINA C, PELU G, CIAMPELLI L. POSSIBILIT'A DI VALUTAZIONE PROGNOSTICA DEL MORBO DI HODGKIN DOPO RADIOTERAPIA. [POSSIBILITY OF PROGNOSTIC EVALUATION OF HODGKIN'S DISEASE AFTER RADIOTHERAPY]. Radiol Med. 1964 Oct;50:1008-25. Italian. PMID: 14219976.
Copy Download .nbib Format: NLM
Bone Marrow CX3CL1/Fractalkine is a New Player of the Pro-Angiogenic Microenvironment in Multiple Myeloma Patients.

Cancers

Marchica V, Toscani D, Corcione A, Bolzoni M, Storti P, Vescovini R, Ferretti E, Dalla Palma B, Vicario E, Accardi F, Mancini C, Martella E, Ribatti D, Vacca A, Pistoia V, Giuliani N.
PMID: 30845779
Cancers (Basel). 2019 Mar 06;11(3). doi: 10.3390/cancers11030321.

C-X3-C motif chemokine ligand 1 (CX3CL1)/fractalkine is a chemokine released after cleavage by two metalloproteases, ADAM metallopeptidase domain 10 (ADAM10) and ADAM metallopeptidase domain 17 (ADAM17), involved in inflammation and angiogenesis in the cancer microenvironment. The role of the...

Cite
Marchica V, Toscani D, Corcione A, et al. Bone Marrow CX3CL1/Fractalkine is a New Player of the Pro-Angiogenic Microenvironment in Multiple Myeloma Patients. Cancers (Basel). 2019;11(3)doi: 10.3390/cancers11030321.
Marchica, V., Toscani, D., Corcione, A., Bolzoni, M., Storti, P., Vescovini, R., Ferretti, E., Dalla Palma, B., Vicario, E., Accardi, F., Mancini, C., Martella, E., Ribatti, D., Vacca, A., Pistoia, V., & Giuliani, N. (2019). Bone Marrow CX3CL1/Fractalkine is a New Player of the Pro-Angiogenic Microenvironment in Multiple Myeloma Patients. Cancers, 11(3), . https://doi.org/10.3390/cancers11030321
Marchica, Valentina, et al. "Bone Marrow CX3CL1/Fractalkine is a New Player of the Pro-Angiogenic Microenvironment in Multiple Myeloma Patients." Cancers vol. 11,3 (2019). doi: https://doi.org/10.3390/cancers11030321
Marchica V, Toscani D, Corcione A, Bolzoni M, Storti P, Vescovini R, Ferretti E, Dalla Palma B, Vicario E, Accardi F, Mancini C, Martella E, Ribatti D, Vacca A, Pistoia V, Giuliani N. Bone Marrow CX3CL1/Fractalkine is a New Player of the Pro-Angiogenic Microenvironment in Multiple Myeloma Patients. Cancers (Basel). 2019 Mar 06;11(3). doi: 10.3390/cancers11030321. PMID: 30845779; PMCID: PMC6469019.
Copy Download .nbib Format: NLM
Myeloma Cells Deplete Bone Marrow Glutamine and Inhibit Osteoblast Differentiation Limiting Asparagine Availability.

Cancers

Chiu M, Toscani D, Marchica V, Taurino G, Costa F, Bianchi MG, Andreoli R, Franceschi V, Storti P, Burroughs-Garcia J, Eufemiese RA, Dalla Palma B, Campanini N, Martella E, Mancini C, Shan J, Kilberg MS, D'Amico G, Dander E, Agnelli L, Pruneri G, Donofrio G, Bussolati O, Giuliani N.
PMID: 33167336
Cancers (Basel). 2020 Nov 05;12(11). doi: 10.3390/cancers12113267.

Multiple myeloma (MM) cells consume huge amounts of glutamine and, as a consequence, the amino acid concentration is lower-than-normal in the bone marrow (BM) of MM patients. Here we show that MM-dependent glutamine depletion induces glutamine synthetase in stromal...

Cite
Chiu M, Toscani D, Marchica V, et al. Myeloma Cells Deplete Bone Marrow Glutamine and Inhibit Osteoblast Differentiation Limiting Asparagine Availability. Cancers (Basel). 2020;12(11)doi: 10.3390/cancers12113267.
Chiu, M., Toscani, D., Marchica, V., Taurino, G., Costa, F., Bianchi, M. G., Andreoli, R., Franceschi, V., Storti, P., Burroughs-Garcia, J., Eufemiese, R. A., Dalla Palma, B., Campanini, N., Martella, E., Mancini, C., Shan, J., Kilberg, M. S., D'Amico, G., Dander, E., Agnelli, L., Pruneri, G., Donofrio, G., Bussolati, O., & Giuliani, N. (2020). Myeloma Cells Deplete Bone Marrow Glutamine and Inhibit Osteoblast Differentiation Limiting Asparagine Availability. Cancers, 12(11), . https://doi.org/10.3390/cancers12113267
Chiu, Martina, et al. "Myeloma Cells Deplete Bone Marrow Glutamine and Inhibit Osteoblast Differentiation Limiting Asparagine Availability." Cancers vol. 12,11 (2020). doi: https://doi.org/10.3390/cancers12113267
Chiu M, Toscani D, Marchica V, Taurino G, Costa F, Bianchi MG, Andreoli R, Franceschi V, Storti P, Burroughs-Garcia J, Eufemiese RA, Dalla Palma B, Campanini N, Martella E, Mancini C, Shan J, Kilberg MS, D'Amico G, Dander E, Agnelli L, Pruneri G, Donofrio G, Bussolati O, Giuliani N. Myeloma Cells Deplete Bone Marrow Glutamine and Inhibit Osteoblast Differentiation Limiting Asparagine Availability. Cancers (Basel). 2020 Nov 05;12(11). doi: 10.3390/cancers12113267. PMID: 33167336; PMCID: PMC7694402.
Copy Download .nbib Format: NLM
In-vacuum sensors for the beamline components of the ITER neutral beam test facility.

The Review of scientific instruments

Dalla Palma M, Pasqualotto R, Sartori E, Spagnolo S, Spolaore M, Veltri P.
PMID: 27910334
Rev Sci Instrum. 2016 Nov;87(11):11D417. doi: 10.1063/1.4959954.

Embedded sensors have been designed for installation on the components of the MITICA beamline, the prototype ITER neutral beam injector (Megavolt ITER Injector and Concept Advancement), to derive characteristics of the particle beam and to monitor the component conditions...

Cite
Dalla Palma M, Pasqualotto R, Sartori E, et al. In-vacuum sensors for the beamline components of the ITER neutral beam test facility. Rev Sci Instrum. 2016;87(11):11D417doi: 10.1063/1.4959954.
Dalla Palma, M., Pasqualotto, R., Sartori, E., Spagnolo, S., Spolaore, M., & Veltri, P. (2016). In-vacuum sensors for the beamline components of the ITER neutral beam test facility. The Review of scientific instruments, 87(11), 11D417. https://doi.org/10.1063/1.4959954
Dalla Palma, M, et al. "In-vacuum sensors for the beamline components of the ITER neutral beam test facility." The Review of scientific instruments vol. 87,11 (2016): 11D417. doi: https://doi.org/10.1063/1.4959954
Dalla Palma M, Pasqualotto R, Sartori E, Spagnolo S, Spolaore M, Veltri P. In-vacuum sensors for the beamline components of the ITER neutral beam test facility. Rev Sci Instrum. 2016 Nov;87(11):11D417. doi: 10.1063/1.4959954. PMID: 27910334.
Copy Download .nbib Format: NLM
Final design of thermal diagnostic system in SPIDER ion source.

The Review of scientific instruments

Brombin M, Dalla Palma M, Pasqualotto R, Pomaro N.
PMID: 27910628
Rev Sci Instrum. 2016 Nov;87(11):11D433. doi: 10.1063/1.4961077.

The prototype radio frequency source of the ITER heating neutral beams will be first tested in SPIDER test facility to optimize H

Cite
Brombin M, Dalla Palma M, Pasqualotto R, et al. Final design of thermal diagnostic system in SPIDER ion source. Rev Sci Instrum. 2016;87(11):11D433doi: 10.1063/1.4961077.
Brombin, M., Dalla Palma, M., Pasqualotto, R., & Pomaro, N. (2016). Final design of thermal diagnostic system in SPIDER ion source. The Review of scientific instruments, 87(11), 11D433. https://doi.org/10.1063/1.4961077
Brombin, M, et al. "Final design of thermal diagnostic system in SPIDER ion source." The Review of scientific instruments vol. 87,11 (2016): 11D433. doi: https://doi.org/10.1063/1.4961077
Brombin M, Dalla Palma M, Pasqualotto R, Pomaro N. Final design of thermal diagnostic system in SPIDER ion source. Rev Sci Instrum. 2016 Nov;87(11):11D433. doi: 10.1063/1.4961077. PMID: 27910628.
Copy Download .nbib Format: NLM
A feasibility study of a static-robotic telepathology system for remote diagnosis.

Advances in clinical pathology : the official journal of Adriatic Society of Pathology

De Michelis F, Eccher C, Clemente C, Migliore G, Dalla Palma P, Forti S.
PMID: 10358343
Adv Clin Path. 1998 Apr;2(2):138-139.

No abstract available.

Cite
De Michelis F, Eccher C, Clemente C, et al. A feasibility study of a static-robotic telepathology system for remote diagnosis. Adv Clin Path. 1998;2(2):138-139
De Michelis F, Eccher, C., Clemente, C., Migliore, G., Dalla Palma P, & Forti, S. (1998). A feasibility study of a static-robotic telepathology system for remote diagnosis. Advances in clinical pathology : the official journal of Adriatic Society of Pathology, 2(2), 138-139.
De Michelis F, et al. "A feasibility study of a static-robotic telepathology system for remote diagnosis." Advances in clinical pathology : the official journal of Adriatic Society of Pathology vol. 2,2 (1998): 138-139.
De Michelis F, Eccher C, Clemente C, Migliore G, Dalla Palma P, Forti S. A feasibility study of a static-robotic telepathology system for remote diagnosis. Adv Clin Path. 1998 Apr;2(2):138-139. PMID: 10358343.
Copy Download .nbib Format: NLM
Novel Approaches to Improve Myeloma Cell Killing by Monoclonal Antibodies.

Journal of clinical medicine

Storti P, Costa F, Marchica V, Burroughs-Garcia J, Dalla Palma B, Toscani D, Eufemiese RA, Giuliani N.
PMID: 32899714
J Clin Med. 2020 Sep 04;9(9). doi: 10.3390/jcm9092864.

The monoclonal antibodies (mAbs) have significantly changed the treatment of multiple myeloma (MM) patients. However, despite their introduction, MM remains an incurable disease. The mAbs currently used for MM treatment were developed with different mechanisms of action able to...

Cite
Storti P, Costa F, Marchica V, et al. Novel Approaches to Improve Myeloma Cell Killing by Monoclonal Antibodies. J Clin Med. 2020;9(9)doi: 10.3390/jcm9092864.
Storti, P., Costa, F., Marchica, V., Burroughs-Garcia, J., Dalla Palma, B., Toscani, D., Eufemiese, R. A., & Giuliani, N. (2020). Novel Approaches to Improve Myeloma Cell Killing by Monoclonal Antibodies. Journal of clinical medicine, 9(9), . https://doi.org/10.3390/jcm9092864
Storti, Paola, et al. "Novel Approaches to Improve Myeloma Cell Killing by Monoclonal Antibodies." Journal of clinical medicine vol. 9,9 (2020). doi: https://doi.org/10.3390/jcm9092864
Storti P, Costa F, Marchica V, Burroughs-Garcia J, Dalla Palma B, Toscani D, Eufemiese RA, Giuliani N. Novel Approaches to Improve Myeloma Cell Killing by Monoclonal Antibodies. J Clin Med. 2020 Sep 04;9(9). doi: 10.3390/jcm9092864. PMID: 32899714; PMCID: PMC7564331.
Copy Download .nbib Format: NLM
New insights into osteogenic and chondrogenic differentiation of human bone marrow mesenchymal stem cells and their potential clinical applications for bone regeneration in pediatric orthopaedics.

Stem cells international

Giuliani N, Lisignoli G, Magnani M, Racano C, Bolzoni M, Dalla Palma B, Spolzino A, Manferdini C, Abati C, Toscani D, Facchini A, Aversa F.
PMID: 23766767
Stem Cells Int. 2013;2013:312501. doi: 10.1155/2013/312501. Epub 2013 May 23.

Human mesenchymal stem cells (hMSCs) are pluripotent adult stem cells capable of being differentiated into osteoblasts, adipocytes, and chondrocytes. The osteogenic differentiation of hMSCs is regulated either by systemic hormones or by local growth factors able to induce specific...

Cite
Giuliani N, Lisignoli G, Magnani M, et al. New insights into osteogenic and chondrogenic differentiation of human bone marrow mesenchymal stem cells and their potential clinical applications for bone regeneration in pediatric orthopaedics. Stem Cells Int. 2013;2013:312501doi: 10.1155/2013/312501.
Giuliani, N., Lisignoli, G., Magnani, M., Racano, C., Bolzoni, M., Dalla Palma, B., Spolzino, A., Manferdini, C., Abati, C., Toscani, D., Facchini, A., & Aversa, F. (2013). New insights into osteogenic and chondrogenic differentiation of human bone marrow mesenchymal stem cells and their potential clinical applications for bone regeneration in pediatric orthopaedics. Stem cells international, 2013312501. https://doi.org/10.1155/2013/312501
Giuliani, Nicola, et al. "New insights into osteogenic and chondrogenic differentiation of human bone marrow mesenchymal stem cells and their potential clinical applications for bone regeneration in pediatric orthopaedics." Stem cells international vol. 2013 (2013): 312501. doi: https://doi.org/10.1155/2013/312501
Giuliani N, Lisignoli G, Magnani M, Racano C, Bolzoni M, Dalla Palma B, Spolzino A, Manferdini C, Abati C, Toscani D, Facchini A, Aversa F. New insights into osteogenic and chondrogenic differentiation of human bone marrow mesenchymal stem cells and their potential clinical applications for bone regeneration in pediatric orthopaedics. Stem Cells Int. 2013;2013:312501. doi: 10.1155/2013/312501. Epub 2013 May 23. PMID: 23766767; PMCID: PMC3676919.
Copy Download .nbib Format: NLM
High energy flux thermo-mechanical test of 1D-carbon-carbon fibre composite prototypes for the SPIDER diagnostic calorimeter.

The Review of scientific instruments

De Muri M, Cavallin T, Pasqualotto R, Dalla Palma M, Cervaro V, Fasolo D, Franchin L, Tollin M, Greuner H, Böswirth B, Serianni G.
PMID: 24593452
Rev Sci Instrum. 2014 Feb;85(2):02A718. doi: 10.1063/1.4827655.

Operation of the thermonuclear fusion experiment ITER requires additional heating via injection of neutral beams from accelerated negative ions. In the SPIDER test facility, under construction in Padova, the production of negative ions will be studied and optimised. STRIKE...

Cite
De Muri M, Cavallin T, Pasqualotto R, et al. High energy flux thermo-mechanical test of 1D-carbon-carbon fibre composite prototypes for the SPIDER diagnostic calorimeter. Rev Sci Instrum. 2014;85(2):02A718doi: 10.1063/1.4827655.
De Muri, M., Cavallin, T., Pasqualotto, R., Dalla Palma, M., Cervaro, V., Fasolo, D., Franchin, L., Tollin, M., Greuner, H., Böswirth, B., & Serianni, G. (2014). High energy flux thermo-mechanical test of 1D-carbon-carbon fibre composite prototypes for the SPIDER diagnostic calorimeter. The Review of scientific instruments, 85(2), 02A718. https://doi.org/10.1063/1.4827655
De Muri, M, et al. "High energy flux thermo-mechanical test of 1D-carbon-carbon fibre composite prototypes for the SPIDER diagnostic calorimeter." The Review of scientific instruments vol. 85,2 (2014): 02A718. doi: https://doi.org/10.1063/1.4827655
De Muri M, Cavallin T, Pasqualotto R, Dalla Palma M, Cervaro V, Fasolo D, Franchin L, Tollin M, Greuner H, Böswirth B, Serianni G. High energy flux thermo-mechanical test of 1D-carbon-carbon fibre composite prototypes for the SPIDER diagnostic calorimeter. Rev Sci Instrum. 2014 Feb;85(2):02A718. doi: 10.1063/1.4827655. PMID: 24593452.
Copy Download .nbib Format: NLM
Prognostic value of p53 expression in early-stage breast-carcinoma compared with tumor angiogenesis, epidermal growth-factor receptor, C-erbb-2, cathepsin-d, DNA-ploidy, parameters of cell-kinetics and conventional features.

International journal of oncology

Gasparini G, Bevilacqua P, Boracchi P, Maluta S, Pozza F, Barbareschi M, Dallapalma P, Mezzetti M, Harris A.
PMID: 21566906
Int J Oncol. 1994 Jan;4(1):155-62. doi: 10.3892/ijo.4.1.155.

p53 expression detected by immunocytochemistry is emerging as a novel potentially useful prognostic indicator in breast carcinoma. However, additional research is warranted because a consensus has not yet been achieved on: i) methodology and quality control issues; ii) its...

Cite
Gasparini G, Bevilacqua P, Boracchi P, et al. Prognostic value of p53 expression in early-stage breast-carcinoma compared with tumor angiogenesis, epidermal growth-factor receptor, C-erbb-2, cathepsin-d, DNA-ploidy, parameters of cell-kinetics and conventional features. Int J Oncol. 1994;4(1):155-62doi: 10.3892/ijo.4.1.155.
Gasparini, G., Bevilacqua, P., Boracchi, P., Maluta, S., Pozza, F., Barbareschi, M., Dallapalma, P., Mezzetti, M., & Harris, A. (1994). Prognostic value of p53 expression in early-stage breast-carcinoma compared with tumor angiogenesis, epidermal growth-factor receptor, C-erbb-2, cathepsin-d, DNA-ploidy, parameters of cell-kinetics and conventional features. International journal of oncology, 4(1), 155-62. https://doi.org/10.3892/ijo.4.1.155
Gasparini, G, et al. "Prognostic value of p53 expression in early-stage breast-carcinoma compared with tumor angiogenesis, epidermal growth-factor receptor, C-erbb-2, cathepsin-d, DNA-ploidy, parameters of cell-kinetics and conventional features." International journal of oncology vol. 4,1 (1994): 155-62. doi: https://doi.org/10.3892/ijo.4.1.155
Gasparini G, Bevilacqua P, Boracchi P, Maluta S, Pozza F, Barbareschi M, Dallapalma P, Mezzetti M, Harris A. Prognostic value of p53 expression in early-stage breast-carcinoma compared with tumor angiogenesis, epidermal growth-factor receptor, C-erbb-2, cathepsin-d, DNA-ploidy, parameters of cell-kinetics and conventional features. Int J Oncol. 1994 Jan;4(1):155-62. doi: 10.3892/ijo.4.1.155. PMID: 21566906.
Copy Download .nbib Format: NLM
Final design of the beam source for the MITICA injector.

The Review of scientific instruments

Marcuzzi D, Agostinetti P, Dalla Palma M, De Muri M, Chitarin G, Gambetta G, Marconato N, Pasqualotto R, Pavei M, Pilan N, Rizzolo A, Serianni G, Toigo V, Trevisan L, Visentin M, Zaccaria P, Zaupa M, Boilson D, Graceffa J, Hemsworth RS, Choi CH, Marti M, Roux K, Singh MJ, Masiello A, Froeschle M, Heinemann B, Nocentini R, Riedl R, Tobari H, de Esch HP, Muvvala VN.
PMID: 26932037
Rev Sci Instrum. 2016 Feb;87(2):02B309. doi: 10.1063/1.4932615.

The megavolt ITER injector and concept advancement experiment is the prototype and the test bed of the ITER heating and current drive neutral beam injectors, currently in the final design phase, in view of the installation in Padova Research...

Cite
Marcuzzi D, Agostinetti P, Dalla Palma M, et al. Final design of the beam source for the MITICA injector. Rev Sci Instrum. 2016;87(2):02B309doi: 10.1063/1.4932615.
Marcuzzi, D., Agostinetti, P., Dalla Palma, M., De Muri, M., Chitarin, G., Gambetta, G., Marconato, N., Pasqualotto, R., Pavei, M., Pilan, N., Rizzolo, A., Serianni, G., Toigo, V., Trevisan, L., Visentin, M., Zaccaria, P., Zaupa, M., Boilson, D., Graceffa, J., Hemsworth, R. S., Choi, C. H., Marti, M., Roux, K., Singh, M. J., Masiello, A., Froeschle, M., Heinemann, B., Nocentini, R., Riedl, R., Tobari, H., de Esch, H. P., & Muvvala, V. N. (2016). Final design of the beam source for the MITICA injector. The Review of scientific instruments, 87(2), 02B309. https://doi.org/10.1063/1.4932615
Marcuzzi, D, et al. "Final design of the beam source for the MITICA injector." The Review of scientific instruments vol. 87,2 (2016): 02B309. doi: https://doi.org/10.1063/1.4932615
Marcuzzi D, Agostinetti P, Dalla Palma M, De Muri M, Chitarin G, Gambetta G, Marconato N, Pasqualotto R, Pavei M, Pilan N, Rizzolo A, Serianni G, Toigo V, Trevisan L, Visentin M, Zaccaria P, Zaupa M, Boilson D, Graceffa J, Hemsworth RS, Choi CH, Marti M, Roux K, Singh MJ, Masiello A, Froeschle M, Heinemann B, Nocentini R, Riedl R, Tobari H, de Esch HP, Muvvala VN. Final design of the beam source for the MITICA injector. Rev Sci Instrum. 2016 Feb;87(2):02B309. doi: 10.1063/1.4932615. PMID: 26932037.
Copy Download .nbib Format: NLM
Limb salvage in diabetic patients with no-option critical limb ischemia: outcomes of a specialized center experience.

Diabetic foot & ankle

Dalla Paola L, Cimaglia P, Carone A, Scavone G, Boscarino G, Bernucci D, Sbarzaglia P, Censi S, Ferrari R, Campo G.
PMID: 31839898
Diabet Foot Ankle. 2019 Nov 28;10(1):1696012. doi: 10.1080/2000625X.2019.1696012. eCollection 2019.

No abstract available.

Cite
Dalla Paola L, Cimaglia P, Carone A, et al. Limb salvage in diabetic patients with no-option critical limb ischemia: outcomes of a specialized center experience. Diabet Foot Ankle. 2019;10(1):1696012doi: 10.1080/2000625X.2019.1696012.
Dalla Paola, L., Cimaglia, P., Carone, A., Scavone, G., Boscarino, G., Bernucci, D., Sbarzaglia, P., Censi, S., Ferrari, R., & Campo, G. (2019). Limb salvage in diabetic patients with no-option critical limb ischemia: outcomes of a specialized center experience. Diabetic foot & ankle, 10(1), 1696012. https://doi.org/10.1080/2000625X.2019.1696012
Dalla Paola, Luca, et al. "Limb salvage in diabetic patients with no-option critical limb ischemia: outcomes of a specialized center experience." Diabetic foot & ankle vol. 10,1 (2019): 1696012. doi: https://doi.org/10.1080/2000625X.2019.1696012
Dalla Paola L, Cimaglia P, Carone A, Scavone G, Boscarino G, Bernucci D, Sbarzaglia P, Censi S, Ferrari R, Campo G. Limb salvage in diabetic patients with no-option critical limb ischemia: outcomes of a specialized center experience. Diabet Foot Ankle. 2019 Nov 28;10(1):1696012. doi: 10.1080/2000625X.2019.1696012. eCollection 2019. PMID: 31839898; PMCID: PMC6896489.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 27 entries